🇨🇦 Canada Country × Condition
melanoma Clinical Trials in Canada
Active clinical trials for melanoma with research sites in Canada. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 1, Phase 3 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇨🇦 Canada
Active Trials in Canada (4)
NCT05620290 Phase 1
Recruiting
MRI-Guided Focused Ultrasound Radiosensitization for Patients With Malignant Melanoma and Non Melanoma Skin Cancer
Enrollment
20 pts
Country
🇨🇦 Canada
Sunnybrook Health Sciences Centre
View Trial → NCT05403177
Recruiting
Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)
Enrollment
500 pts
Country
🇨🇦 Canada
University Health Network, Toronto
View Trial → NCT05645510
Recruiting
LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study
Enrollment
75 pts
Country
🇨🇦 Canada
University of Alberta
View Trial → NCT06246916 Phase 3
Recruiting
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Enrollment
560 pts
Country
🇨🇦 Canada
Regeneron Pharmaceuticals
View Trial → Frequently Asked Questions
How many melanoma clinical trials are active in Canada?
There are currently 4 active clinical trials for melanoma with sites in Canada, of which 4 are actively recruiting patients.
How can I join a melanoma clinical trial in Canada?
To join a melanoma clinical trial in Canada, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Canada directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are melanoma trials in Canada?
Active melanoma trials in Canada span Phase 1, Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology